Tyndall Capital Partners L P, 10% Owner at Onconova Therapeutics, Inc. (ONTX), bought 20,294,116 shares at $0.43 ($8.7M) on 2018-04-27, disclosed to the SEC on 2018-05-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.43 | 10,147,058 | $4.4M | 50.0% |
| 2 | $0.43 | 10,147,058 | $4.4M | 50.0% |
| Total | $0.43 avg | 20,294,116 | $8.7M | 100% |
| Filing → |
| ONTX | SELL | 2019-09-20 | $210K | — | Filing → |
| ONTX | SELL | 2019-09-13 | $3K | — | Filing → |
| ONTX | SELL | 2019-09-11 | $1K | — | Filing → |